Consistency among these results is highly significant because changes in the macular pigment measured, in response to carotenoid vitamin therapy, substantiate the role of MPOD status in representing a pharmacodynamic/response biomarker in the context of AMD.
← all excerpts
A Systematic Review of Carotenoids in the Management of Age-Related Macular Degeneration.
1
—
—